DICE Therapeutics, Inc. (DICE): Price and Financial Metrics


DICE Therapeutics, Inc. (DICE): $14.99

0.50 (+3.45%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add DICE to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

DICE Stock Price Chart Interactive Chart >

Price chart for DICE

DICE Price/Volume Stats

Current price $14.99 52-week high $40.50
Prev. close $14.49 52-week low $13.39
Day low $13.97 Volume 813,900
Day high $15.13 Avg. volume 332,246
50-day MA $18.63 Dividend yield N/A
200-day MA $0.00 Market Cap 573.05M

DICE Therapeutics, Inc. (DICE) Company Bio


DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lead therapeutic candidate is S011806, an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17, which is a validated drug target implicated in a various immunology indications. It is also developing oral therapeutic candidates targeting a4ß7 integrin for the treatment of inflammatory bowel diseases, as well as targeting aVß1/aVß6 integrin for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2013 and is headquartered in South San Francisco, California.


DICE Latest News Stream


Event/Time News Detail
Loading, please wait...

DICE Latest Social Stream


Loading social stream, please wait...

View Full DICE Social Stream

Latest DICE News From Around the Web

Below are the latest news stories about DICE Therapeutics Inc that investors may wish to consider to help them evaluate DICE as an investment opportunity.

What Type Of Shareholders Own The Most Number of DICE Therapeutics, Inc. (NASDAQ:DICE) Shares?

Every investor in DICE Therapeutics, Inc. ( NASDAQ:DICE ) should be aware of the most powerful shareholder groups...

Yahoo | February 13, 2022

DICE Therapeutics to Present at the 11th Annual SVB Leerink Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- DICE Therapeutics, Inc. (Nasdaq: DICE), a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas, today announced that management will present at the 11 th Annual SVB Leerink Global Healthcare Conference on Thursday, February 17 at 4:20 p.m. ET.

GlobeNewswire | February 10, 2022

DICE Therapeutics, Inc. (NASDAQ:DICE) may have lost US$125m in value but insiders who invested last year have seen gains of around US$45k to date

Insiders who bought DICE Therapeutics, Inc. ( NASDAQ:DICE ) in the last 12 months may probably not pay attention to the...

Yahoo | December 15, 2021

DICE Therapeutics (NASDAQ:DICE) Trading Up 3.1%

DICE Therapeutics Inc (NASDAQ:DICE) was up 3.1% on Tuesday . The company traded as high as $30.02 and last traded at $27.86. Approximately 725,139 shares traded hands during trading, an increase of 277% from the average daily volume of 192,514 shares. The stock had previously closed at $27.01. Several research firms have recently commented on []

Dakota Financial News | December 9, 2021

DICE Therapeutics to Present at November Investor Conferences

SOUTH SAN FRANCISCO, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) -- DICE Therapeutics, Inc. (Nasdaq: DICE), a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas, today announced that management will participate in the following investor conferences in November: 33rd Annual Piper Sandler Virtual Healthcare Conference. A pre-recorded fireside chat with DICE

Yahoo | November 16, 2021

Read More 'DICE' Stories Here

DICE Price Returns

1-mo -25.24%
3-mo -20.81%
6-mo -52.22%
1-year N/A
3-year N/A
5-year N/A
YTD -40.77%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8045 seconds.